Patents by Inventor Stephen Cohn

Stephen Cohn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070072928
    Abstract: The present invention is directed to substituted propylamine derivatives of formula I: or a pharmaceutically acceptable salt thereof, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, and combinations thereof, particularly those conditions selected from the group consisting of major depressive disorder, vasomotor symptoms, stress and urge urinary incontinence, fibromyalgia, pain, diabetic neuropathy, and combinations thereof.
    Type: Application
    Filed: September 27, 2006
    Publication date: March 29, 2007
    Applicant: Wyeth
    Inventors: Casey McComas, Puwen Zhang, Eugene Terefenko, An Vu, Stephen Cohn
  • Publication number: 20070072897
    Abstract: The present invention is directed to phenylaminopropanol derivatives of formulae I, II, and III: or a pharmaceutically acceptable salt thereof, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromyalgia syndrome, nervous system disorders, and combinations thereof, particularly those conditions selected from the group consisting of major depressive disorder, vasomotor symptoms, stress and urge urinary incontinence, fibromyalgia, pain, diabetic neuropathy, schizophrenia, and combinations thereof.
    Type: Application
    Filed: September 27, 2006
    Publication date: March 29, 2007
    Applicant: Wyeth
    Inventors: Paige Mahaney, Gavin Heffernan, Richard Coghlan, Stephen Cohn, Callain Kim, Douglas Jenkins, Michael Marella, Casey McComas, Joseph Sabatucci, Eugene Terefenko, Eugene Trybulski, An Vu, Fei Ye, Puwen Zhang
  • Publication number: 20070043077
    Abstract: This invention provides estrogen receptor modulators having the structure where R1—R5 are defined in the specification; or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 31, 2006
    Publication date: February 22, 2007
    Applicant: Wyeth
    Inventors: Richard Mewshaw, Stephen Cohn
  • Publication number: 20060217399
    Abstract: This invention provides estrogen receptor modulators of formula I, having the structure wherein, R1, R2, R3, R4, R5, and R6 are as defined in the specification, or a N-oxide thereof or a pharmaceutically acceptable salt thereof or a prodrug thereof.
    Type: Application
    Filed: May 31, 2006
    Publication date: September 28, 2006
    Applicant: Wyeth
    Inventors: An Vu, Stephen Cohn, Richard Mewshaw
  • Publication number: 20050222148
    Abstract: The present invention is directed to phenylaminopropanol derivatives of formula I: or a pharmaceutically acceptable salt thereof, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, and combinations thereof, particularly those conditions selected from the group consisting of major depressive disorder, vasomotor symptoms, stress and urge urinary incontinence, fibromyalgia, pain, diabetic neuropathy, and combinations thereof.
    Type: Application
    Filed: March 28, 2005
    Publication date: October 6, 2005
    Applicant: Wyeth
    Inventors: Callain Kim, Paige Mahaney, Eugene Trybulski, Puwen Zhang, Eugene Terefenko, Casey McComas, Michael Marella, Richard Coghlan, Gavin Heffernan, Stephen Cohn, An Vu, Joseph Sabatucci, Fei Ye
  • Publication number: 20050222142
    Abstract: The present invention is directed to phenylaminopropanol derivatives of formula I: or a pharmaceutically acceptable salt thereof, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, and combinations thereof, particularly those conditions selected from the group consisting of major depressive disorder, vasomotor symptoms, stress and urge urinary incontinence, fibromyalgia, pain, diabetic neuropathy, and combinations thereof.
    Type: Application
    Filed: March 28, 2005
    Publication date: October 6, 2005
    Applicant: Wyeth
    Inventors: An Vu, Paige Mahaney, Stephen Cohn
  • Publication number: 20050182709
    Abstract: A financial scenario modeling and analysis tool, including a graphical user interface which enables a user of the tool to create a graphical model of a financial scenario, generally including at least one financial transaction, on a display screen, and an engine operable, in response to creation of the graphical model, to automatically generate information, such as financial or mathematical information, which at least partially models at least a part of the financial scenario using information collected by the engine during creation of the graphical model. The graphical user interface enables the user to create party graphics respectively representing parties to the financial deal, and to generate financial instrument graphics representing financial instruments, wherein each financial instrument graphic connects two of the party graphics.
    Type: Application
    Filed: April 11, 2005
    Publication date: August 18, 2005
    Applicant: Babcock & Brown LP, a Delaware limited partnership
    Inventors: Ladislav Belcsak, Luke Lee, David Collop, Mark Bewsher, Thadeus Niemira, Dennis Moritz, Stephen Cohn
  • Publication number: 20050143579
    Abstract: The present invention is directed to substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, and combinations thereof, particularly those conditions selected from the group consisting of major depressive disorder, vasomotor symptoms, stress and urge urinary incontinence, fibromyalgia, pain, diabetic neuropathy, and combinations thereof.
    Type: Application
    Filed: October 12, 2004
    Publication date: June 30, 2005
    Applicant: Wyeth
    Inventors: Eugene Trybulski, Joseph Sabatucci, An Vu, Stephen Cohn, Arthur Santilli, Lori Gavrin, Fei Ye, Paige Mahaney
  • Publication number: 20050009907
    Abstract: This invention provides estrogen receptor modulators having the structure where R1-R5 are as defined in the specification; or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 13, 2004
    Publication date: January 13, 2005
    Inventors: Richard Mewshaw, Stephen Cohn
  • Publication number: 20050009784
    Abstract: This invention provides estrogen receptor modulators of formula I, having the structure wherein, R1, R2, R3, R4, R5, and R6 are as defined in the specification, or a N-oxide thereof or a pharmaceutically acceptable salt thereof or a prodrug thereof.
    Type: Application
    Filed: May 13, 2004
    Publication date: January 13, 2005
    Inventors: An Vu, Stephen Cohn, Richard Mewshaw
  • Patent number: D459759
    Type: Grant
    Filed: May 25, 2001
    Date of Patent: July 2, 2002
    Assignee: Aristocrat Technologies Australia Pty, Ltd.
    Inventors: Barry Shepherd, Stephen Cohn